Enovis (ENOV) Share-based Compensation (2010 - 2026)
Enovis' (ENOV) quarterly Share-based Compensation came in at $9.0 million in Q3 2026, up 3.46% year-over-year from $8.7 million in Q3 2025, and up 2.49% quarter-over-quarter from $8.8 million in Q2 2026.
Analysis
Enovis (ENOV) Share-based Compensation (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Share-based Compensation for 17 consecutive years, with $9.0 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Share-based Compensation rose 3.46% year-over-year to $9.0 million in Q3 2026; TTM through Jul 2026 was $46.1 million, a 199.62% increase from a year earlier, with the FY2025 full-year figure at $44.4 million, down 2.56% from the prior year.
- Share-based Compensation was $9.0 million for Q3 2026 at Enovis, up from $8.8 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $107.9 million in Q1 2024 and troughed at -$62.3 million in Q4 2024.
- A 5-year average of $11.3 million and a median of $8.8 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 1115700.0% in 2022 and plunged 849.99% in 2024, its largest moves.
- Over 5 years, Share-based Compensation stood at $11.2 million in 2022, then decreased by 25.54% to $8.3 million in 2023, then sank by 849.99% to -$62.3 million in 2024, then surged by 131.46% to $19.6 million in 2025, then sank by 54.25% to $9.0 million in 2026.
- The last three Share-based Compensation figures came in at $9.0 million (Q3 2026), $8.8 million (Q2 2026), and $19.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Enovis | 1.07 Bn | 1.05 Bn | 359.25 Mn | 8.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 8.97 Mn |
| Apr 3, 2026 | 8.75 Mn |
| Dec 31, 2025 | 19.60 Mn |
| Oct 3, 2025 | 8.73 Mn |
| Jul 4, 2025 | 8.67 Mn |
| Apr 4, 2025 | 7.41 Mn |
| Dec 31, 2024 | -62.30 Mn |
| Mar 29, 2024 | 107.88 Mn |
| Dec 31, 2023 | 8.31 Mn |
| Sep 29, 2023 | 8.78 Mn |
| Jun 30, 2023 | 16.14 Mn |
| Mar 31, 2023 | 838,000.00 |
| Dec 31, 2022 | 11.16 Mn |
| Sep 30, 2022 | 8.01 Mn |
| Jul 1, 2022 | 9.94 Mn |
| Apr 1, 2022 | 9.86 Mn |
| Dec 31, 2021 | -1,000.00 |
| Oct 1, 2021 | 268.42 Mn |
| Jul 2, 2021 | 9.46 Mn |
| Apr 2, 2021 | 7.81 Mn |